Coloplast A/S Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| PG | Procter & Gamble | Outperform |
12
|
$163.84 | $166.80 | 5.90% | 5 | $385.65B |
| JNJ | Johnson & Johnson | Outperform |
9
|
$149.92 | $174.55 | 13.39% | 3 | $364.31B |
| PFE | Pfizer | Outperform |
2
|
$27.70 | $32.87 | 10.11% | 6 | $153.91B |
| ULVR | Unilever PLC | Hold |
8
|
£41.80 | £50.61 | 19.71% | 12 | £103.61B |
| SAN | Sanofi | Outperform |
16
|
91.90€ | 102.80€ | 18.61% | 9 | 116.22€B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$43.70 | $58.15 | 23.57% | 10 | $88.58B |
| RKT | Reckitt Benckiser Group | Outperform |
12
|
£44.69 | £66.68 | 20.83% | 12 | £31.55B |
| BEI | Beiersdorf | Outperform |
17
|
142.15€ | 137.41€ | 4.82% | 3 | 31.46€B |
| BAYN | Bayer | Hold |
5
|
28.13€ | 45.15€ | 6.65% | 4 | 26.87€B |
| CLX | Clorox Co-The | Hold |
16
|
$139.67 | $154.18 | 8.47% | 9 | $17.34B |
| SN. | Smith & Nephew | Outperform |
18
|
£9.86 | £16.09 | 65.52% | 10 | £8.54B |
| CTEC | ConvaTec Group PLC | Outperform |
16
|
£2.49 | £3.43 | 59.44% | 6 | £5.03B |
| PRGO | Perrigo Co PLC | Buy |
16
|
$33.06 | $44.75 | 20.99% | 0 | $4.43B |
| HYPE3 | Hypera | Outperform |
16
|
R$29.79 | R$45.97 | 38.47% | 3 | R$18.69B |
| AXNX | Axonics | Hold |
7
|
$67.11 | $70.15 | 5.80% | 2 | $3.40B |
| IART | Integra LifeSciences Holdings | Hold |
16
|
$28.75 | $46.60 | 51.30% | 4 | $2.29B |
| ORGO | Organogenesis Holdings | Outperform |
10
|
$2.49 | $4.75 | 100.80% | 1 | $311.55M |
| CLGN | CollPlant Biotechnologies | Buy |
7
|
$5.55 | $0.00 | 204.14% | 0 | $65.00M |
| 540468 | KMS Medisurgi | - |
0
|
34.35 | 0.00 | -100.00% | 0 | 113.03M |